From: Risk factors associated with acute kidney injury in a cohort of hospitalized patients with COVID-19
Characteristic | No AKI (n = 846) | AKI (n = 738) | p-value |
---|---|---|---|
Age, median in years (IQR) | 61 (23) | 66 (19) | < 0.001 |
Gender—males, n (%) | 436 (51.5) | 520 (70.5) | < 0.001 |
Days from symptoms onset to admission, median in days (IQR) | 7 (6) | 6 (4) | 0.102 |
Overweight or obesity, n (%) | 178 (21) | 215 (29.1) | < 0.001 |
Tobacco use, n (%) | 188 (22.2) | 215 (29.1) | 0.002 |
Diabetes mellitus, n (%) | 152 (18) | 173 (23.4) | 0.007 |
High blood pressure, n (%) | 299 (35.3) | 365 (49.5) | < 0.001 |
Chronic kidney disease, n (%) | 22 (2.6) | 79 (10.7) | < 0.001 |
Heart failure, n (%) | 37 (4.4) | 69 (9.4) | < 0.001 |
Charlson comorbidity index, n (%) | |||
Low comorbidity (CCI ≤ 2) | 797 (94.2) | 648 (87.8) | |
High comorbidity (CCI ≥ 3) | 49 (5.8) | 90 (12.2) | |
Immunosuppression, n (%) | 4 (0.5) | 5 (0.7) | 0.589 |
Previous treatment | < 0.001 | ||
Immunosupressive, n (%) | 19 (2.3) | 16 (2.2) | 0.916 |
Antihipertensives, n (%) | 622 (73.5) | 506 (68.6) | 0.030 |
Non IACE/ARAII antihipertensives, n (%) | 96 (11.4) | 151 (20.5) | < 0.001 |
Statins, n (%) | 542 (64.1) | 406 (55) | < 0.001 |
Diuretics, n (%) | 517 (61.1) | 365 (49.5) | < 0.001 |
NSAIDs, n (%) | 26 (3.1) | 48 (6.5) | 0.001 |
Body temperature at admission, median in degrees Celsius (IQR) | 36.7 (1) | 36.6 (0.7) | 0.014 |
Fever at admission, n (%) | 101 (12.2) | 81 (11.5) | 0.682 |
Sistolic arterial pressure at admission, median in mmHg (IQR) | 123 (25) | 123 (29.5) | 0.059 |
Diastolic arterial pressure at admission, median in mmHg (IQR) | 75 (14) | 74 (17) | 0.001 |
Blood oxygen saturation at admission, median in % (IQR) | 88 (8) | 88 (10) | 0.408 |
qSOFA at admission, n (%) | < 0.001 | ||
qSOFA 0 | 385 (45.5) | 269 (26.5) | |
qSOFA ≥ 1 | 461 (54.5) | 469 (63.5) | |
PaFi at admission, median (IQR) | 262 (106) | 217 (159) | < 0.001 |
PAFI by severity, n (%) | < 0.001 | ||
PaFi ≥ 300 | 653 (77.2) | 428 (58) | |
PaFi 101—299 | 140 (16.6) | 182 (24.7) | |
PaFi ≤ 100 | 53 (6.3) | 128 (17.3) | |
Lymphocyte count at admission, median in cells × 10^3/ul (IQR) | 1.1 (0.7) | 0.8 (0.7) | < 0.001 |
C-reactive protein at admission, median in mg/l (IQR) | 91.7 (119.9) | 128.4 (135.4) | < 0.001 |
Creatinine at admission, median in mg/dl (IQR) | 0.8 (0.3) | 1.1 (0.4) | < 0.001 |
Blood ureic nitrogen at admission, median in mg/dl (IQR) | 15.5 (7.5) | 24.2 (18.3) | < 0.001 |
Sodium at admission, median in mmol/l (IQR) | 137 (5) | 137 (6.7) | 0.296 |
Lactate dehydrogenase at admission, median in U/l (IQR) | 325.5 (164.1) | 386.5 (250.4) | < 0.001 |
D-dimer at admission, median in ng/ml (IQR) | 776 (931) | 1,055 (1,561) | < 0.001 |
Platelets al admission, median in cells × 10^3/ul (IQR) | 226 (113.9) | 211 (118) | < 0.001 |